Loading...
Market
Will a major pharmaceutical company publicly oppose RFK Jr.'s nomination by January 31, 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official statements or press releases from major pharmaceutical companies
Story
Trump's Cabinet Picks Approved by 54%, RFK Jr. Nominated for HHS Secretary, Causing Panic Among Lobbyists and Big Pharma
Nov 21, 2024, 02:08 AM
President-elect Donald Trump is assembling his second administration, focusing on individuals who were his strongest supporters during the 2024 campaign. His cabinet selections have received approval from 54% of voters, with 38% disapproving. This approval rating is slightly lower than the 60% approval President Biden received for his nominations four years ago. A notable nomination is that of Robert F. Kennedy Jr. (RFK Jr.) for the position of Health and Human Services (HHS) Secretary, causing reported panic among lobbyists and Big Pharma companies in Washington. Trump's choices are seen as both a move for reform and a form of revenge against the establishment.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Launches public campaign • 25%
Engages in lobbying efforts • 25%
No significant response • 25%
Other actions • 25%
Strong Support • 25%
Cautious Support • 25%
Concern • 25%
Strong Opposition • 25%
Yes • 50%
No • 50%
Supportive • 25%
Opposed • 25%
Neutral • 25%
Mixed • 25%
Supportive • 25%
Neutral • 25%
Critical • 25%
No official reaction • 25%
Yes • 50%
No • 50%
Significant Increase • 25%
Moderate Increase • 25%
No Significant Change • 25%
Decrease • 25%
Supportive • 25%
Opposed • 25%
Neutral • 25%
No Comment • 25%
